HMOX1 and Alzheimer disease: Together with the attenuation of cognitive decline, imaging, and neuropathological alterations, the results of these experiments suggest that the severity of age-related Alzheimer's-type dementia may be mitigated by augmentation of naturally occurring HO-1 activity, with outcomes expected to include significantly reduced oxidative stress and reduced severity of AD symptoms.